Skip to main content
Botanical Identity Testing

Cassia vs. Ceylon: Why the Cinnamon in Your Supplement Formula May Already Exceed EU Coumarin Limits

Cassia cinnamon contains up to 12,000 mg/kg of coumarin — 120× more than Ceylon. Learn what analytical testing labs find and how to fix your raw material spec.

Nour Abochama VP Operations, Qalitex | Quality Consultant, Ayah Labs

Key Takeaway

Cassia cinnamon contains up to 12,000 mg/kg of coumarin — 120× more than Ceylon. Learn what analytical testing labs find and how to fix your raw material spec.

Cassia cinnamon can contain as much as 12,000 mg of coumarin per kilogram of raw material. Ceylon cinnamon, from a botanically distinct species, typically runs below 250 mg/kg — and often below 100. That’s not a rounding difference. It’s the gap between a finished product that passes a European retailer’s raw material audit and one that lands on a rejection report.

Most supplement brands purchasing “cinnamon bark powder” or “cinnamon extract” don’t know which species is in the bag. The supplier COA lists an extract ratio, a cinnamaldehyde percentage, and maybe a country of origin. Coumarin content? Almost never disclosed — not because the supplier is necessarily hiding it, but because nobody specified it in the purchase order.

That omission is fixable. But you need to understand the chemistry, the regulations, and what analytical testing labs actually run before you can fix it.

The Two Cinnamons: Botanically Distinct, Commercially Confused

Cassia (Cinnamomum cassia, also marketed as Cinnamomum aromaticum) and Ceylon cinnamon (Cinnamomum verum, sometimes labeled C. zeylanicum) are related but meaningfully different plants. Both deliver cinnamaldehyde — the compound behind cinnamon’s characteristic aroma and the metabolic activity supplement brands are formulating around. As a fine brown powder, they’re nearly indistinguishable visually. But at the level of secondary metabolite biosynthesis, they behave very differently.

Cinnamomum verum expresses a biosynthetic pathway that converts coumarin into other phenolic compounds, keeping the compound’s accumulation low throughout the plant tissue. Cinnamomum cassia doesn’t suppress coumarin in the same way, and it accumulates — particularly in the bark, which is the plant part most often used in supplement raw materials. That’s not a deficiency; it’s just chemistry. But it’s chemistry that your incoming QC program needs to account for.

Species-level identification of cinnamon is harder than it sounds once you’re working with an extract or a fine powder. Visual inspection won’t separate them. Organoleptic evaluation won’t either. Even HPLC-based cinnamaldehyde quantification doesn’t distinguish the two species — both produce cinnamaldehyde. You need testing that targets botanical identity specifically: HPTLC using authenticated reference standards, or DNA barcoding with ITS2 or trnL markers matched to a verified reference database.

Without one of those methods in your incoming raw material program, you’re trusting the species declaration on the COA. That’s a reasonable starting assumption for first-lot supplier qualification. It’s not a defensible ongoing QC program.

What Coumarin Levels Actually Look Like Across Incoming Lots

Coumarin content in cassia isn’t fixed. It varies by plant part, geographic origin, growing conditions, and extraction method. Bark consistently contains higher coumarin than inner quills. Vietnamese and Chinese cassia cultivars trend toward the upper end of reported ranges. Certain extraction processes concentrate coumarin further; others partially deplete it.

When running HPLC coumarin quantification on incoming cinnamon lots from multiple suppliers — all of whom declared cassia on the COA — the variation we’ve observed spans from roughly 800 mg/kg to over 9,500 mg/kg within a single calendar year. That range doesn’t imply fraud across every supplier. It reflects natural supply chain variation in a commodity botanical. But it’s variation with real consequences for your formulation math.

Consider a typical cinnamon supplement: a product delivering 500 mg of cassia bark powder per capsule from a lot testing at 8,000 mg/kg coumarin would deliver approximately 4.0 mg of coumarin per capsule. At a standard two-capsule daily serving — common for blood sugar support and metabolic health products — that’s 8.0 mg of coumarin per day. A 70 kg adult’s EU tolerable daily intake is 7.0 mg. One serving already overshoots it.

This isn’t hypothetical. Analytical testing labs that specialize in botanical raw materials encounter this regularly. The finished product looks fine on label review. The cinnamaldehyde content is where the brand specified it. Nobody ran coumarin. Nobody knew.

EU Regulatory Limits — and the US Regulatory Gap Every Brand Should Understand

The European Food Safety Authority evaluated coumarin safety in 2008, establishing a TDI of 0.1 mg/kg body weight per day — based on hepatotoxic effects observed in rodent studies and evidence of inter-individual variability in human coumarin metabolism via the CYP2A6 pathway. The European Commission subsequently set maximum limits under Regulation (EC) No 1334/2008 on flavouring substances: 0.1 mg/kg in general food products, with carved-out allowances for specific traditional categories, including 2 mg/kg in certain breakfast cereals and 50 mg/kg in traditional seasonal baked goods like German Zimtsterne.

For dietary supplements — which most EU member states classify as foods rather than medicinal products — the 0.1 mg/kg general limit applies to the finished product. A cinnamon supplement containing cassia at typical commercial concentrations won’t pass this limit without significant dose reduction or a switch to C. verum.

The US regulatory position is materially different. There is no per-serving coumarin limit for dietary supplements codified in 21 CFR. Coumarin appears on FDA’s restricted list as a standalone food flavoring compound — it’s not GRAS for intentional flavoring use — but when it’s incidental to a botanical raw material under DSHEA, the agency hasn’t established a numerical threshold. A responsible manufacturer accounting for coumarin exposure in their safety assessment is doing the right thing. But the regulatory floor is lower than in the EU.

This asymmetry matters most for brands with European distribution — including EU-facing Amazon marketplaces, UK health food retailer networks, or international private-label customers. A product that’s fully DSHEA-compliant and legally sellable in the US can fail qualification at a German distributor’s QA desk on coumarin alone. We’ve seen it happen. It’s avoidable with the right testing at the raw material stage.

What Analytical Testing Labs Run to Actually Answer the Question

Managing coumarin risk requires two stages of testing. Both are necessary — one without the other leaves a gap that will catch you eventually.

Stage one: botanical identity confirmation. HPTLC using authenticated reference standards from USP or AHPA botanical reference collections produces chromatographic fingerprints that reliably separate C. verum from C. cassia in a powdered extract or ground bark. The fingerprints are distinct once you have validated reference material to compare against. DNA barcoding adds a molecular layer — particularly valuable when the sample is a highly processed extract where secondary metabolites have been partially degraded and morphological markers are absent. Under 21 CFR 111.75(a)(1), identity must be confirmed for each dietary ingredient; either method satisfies the regulatory requirement. Using both gives you layered documentation that holds up under supplier disputes or FDA inspection scrutiny.

Stage two: coumarin quantification by HPLC. A validated HPLC-UV or HPLC-DAD method using a certified coumarin reference standard will quantify coumarin content and express it in mg/kg. That result should then be back-calculated to per-serving coumarin exposure at your formulation’s actual serving weight — a step that most experienced analytical testing labs will perform if you provide the formulation parameters. The output: the species in the bag, the coumarin concentration in that specific lot, and the per-serving dose your finished product will deliver.

What you do with that data — adjust species sourcing, revise the serving size, add a maximum coumarin limit to your raw material spec — is a formulation and regulatory decision. But you cannot make an informed decision without it.

Building Coumarin Risk Into Your Supplier Qualification Program

Adjusting your raw material specification is the practical fix, and it’s not complicated. A defensible cinnamon specification includes four elements your current spec sheet probably doesn’t have:

Species declaration at the PO level. Specify Cinnamomum verum or Cinnamomum cassia explicitly in both the purchase order and the incoming QC specification. “Cinnamon” is not a species designation. If you want Ceylon cinnamon because of its lower coumarin profile, write that requirement into the supplier agreement. Ambiguity in raw material nomenclature is how mixed-species lots become your quality team’s problem rather than your supplier’s.

A numerical maximum coumarin limit. A spec of ≤250 mg/kg effectively requires C. verum — cassia cannot reliably meet it. A spec of ≤2,000 mg/kg allows cassia sourcing while creating a meaningful accountability threshold. Either limit is more defensible than no limit, which is the default for most brands right now.

Per-lot confirmation testing. Coumarin content is not stable across lots from the same supplier. Your SOPs should require botanical identity confirmation and coumarin quantification on every incoming lot — not on an annual basis and not only on first-lot qualification from a new source. The supply chain is dynamic; your testing frequency should reflect that.

COA review criteria for your receiving team. Train your incoming QC staff to hold any cinnamon COA that omits botanical species designation or coumarin content pending retest before production release. A complete COA for this raw material should specify both. If it doesn’t, the lot doesn’t move until testing confirms what’s in the bag.

For any formula with EU distribution, add one final step before launch: run the per-serving coumarin exposure math against the applicable EU maximum limit and document the calculation in your product safety file. Do that during formulation — not after a retail partner’s QA team raises it as a condition of listing.

The data is accessible. The testing is straightforward. The specification language takes an afternoon to draft. The only thing standing between your cinnamon formula and a coumarin problem is whether you ask for the number before or after something goes wrong.


Written by Nour Abochama, VP Operations, Qalitex | Quality Consultant, Ayah Labs. Learn more about our team

Ship your sample to our Chicago facility — get a Qalitex CoA in 5–7 days Contact us

Nour Abochama

Written by

Nour Abochama

VP Operations, Qalitex | Quality Consultant, Ayah Labs

Chemical engineer with 17+ years of experience in laboratory operations, quality assurance, and regulatory compliance. Expert in herbal and supplement testing, botanical identity, contract laboratory services, and ISO 17025 quality systems. Master's in Biomedical Engineering from Grenoble INP – Ense3. Former Director of Quality at American Testing Labs and Labofine. Executive Producer and co-host of the Nourify-Beautify Podcast.

Chemical Engineering17+ Years Lab OperationsISO 17025 (via Qalitex)Herbal & Supplement Testing Specialist
View LinkedIn Profile →

Need contract testing?

Get a quote from Ayah Labs. 48-hour turnaround for chemistry tests. Signed CoA included.

Get a Testing Quote →